BIT biotron limited

0.00%

0.2¢

Again - my eternal question that never gets answered - WHAT...

First 9 Last

Share
Profile

Follow
Footmax

15,569 Posts.

2786

27/03/25

14:54

Post #: 78442587
Share

Again - my eternal question that never gets answered - WHAT DEAL?

Surely, there can't be anyone on this forum that actually believes a deal can be achieved.

What does BIT have to offer to get a deal. There needs to be something outstanding for anyone to be interested in BIT and they have nothing that anyone has been interested in.

Originally posted by a2zz: ↑

BoD is immaterial. (a) Get a deal and ask for money. (b) Stay unpaid until a deal is done. (c) Stay unpaid until voluntary admin.
No rocket science no trial no complex data analyses required for a, b, c
Why on earth should people give money to fund their lifestyle. Only the BoD and MM and their buddies can fund the C14 process and others until deal is done.
They are likely to extend the deadline for rights issue. Let them extend the deadline until C14 comes with some tangible outcomes, if at all, to prove that both BIT and C14 are true entities. So far C14 appears to be a paid service like what GY mentioned to linger the process to statisfy their hunger for getting paid. C14 is a plot to divert attention form the prolonged delay of final results analyses. C14 was selected in way to show excuses of year endign and year starting delay. But they did not delay getting paid to avoid cash burn. C14 is an imaginary service. If regulator had concern of the $70 [GY's post] paid to Biotron over the years, the regulaors would chat with the C14 to know more to safegurad the interests of the SHs and tax payers. BoD and MM may be brought to justice to repay the money by selling whatever they have if they are found misleading. If no misleading, noble proses for MM and BoD only when commercial deal is signed

Expand

BIT Price at posting: 0.3¢ Sentiment: Sell Disclosure: Not Held
5 Upvote

1 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

'Not possible' to port renewable gas: ACCC takes AGN to court

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$210	104.8K

Buyers (Bids)

No.	Vol.	Price($)
64	38848316	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	18281126	25

View Market Depth

No.	Vol.	Price($)
64	38848316	0.002
33	65631001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	18281126	25
0.004	12820969	17
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 12.28pm 27/06/2025 (20 minute delay)

BIT (ASX) Chart

Again - my eternal question that never gets answered - WHAT...

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

'Not possible' to port renewable gas: ACCC takes AGN to court

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Again - my eternal question that never gets answered - WHAT...

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

'Not possible' to port renewable gas: ACCC takes AGN to court

Boss extends June win streak with boosted Alta Mesa extraction rates

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News